SLC7A11 and triple-negative breast carcinoma: Recent studies have demonstrated that in triple-negative breast cancer (TNBC), a substantial decrease in cancer cell GSH levels and a significant increase in cellular superoxide levels can be induced by the administration of a dual metabolic inhibitor of GLS and xCT (SLC7A11), which promotes apoptosis [46].